A 734-case cohort study from the GTE (Groupe d'étude des Tumeurs Endocrines).

[1]  Alberto Fernández,et al.  Prevalence of pituitary adenomas: a community‐based, cross‐sectional study in Banbury (Oxfordshire, UK) , 2010, Clinical endocrinology.

[2]  R. Thakker,et al.  Diagnostic challenges due to phenocopies: lessons from Multiple Endocrine Neoplasia type1 (MEN1) , 2010, Human mutation.

[3]  A. Tabarin,et al.  Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d’Etude des Tumeurs Endocrines) Cohort Study Among 758 Patients , 2010, World Journal of Surgery.

[4]  M. Brandi,et al.  Multiple endocrine neoplasia type I variants and phenocopies: more than a nosological issue? , 2009, The Journal of clinical endocrinology and metabolism.

[5]  A. Tabarin,et al.  Thymic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1: A Comparative Study on 21 Cases Among a Series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines) , 2009, World Journal of Surgery.

[6]  G. Doherty,et al.  Multiple endocrine neoplasia. , 2008, Surgical oncology clinics of North America.

[7]  M. Rothmund,et al.  Age‐related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers , 2007, Clinical endocrinology.

[8]  L. Niskanen,et al.  Multiple endocrine neoplasia type 1 in Northern Finland; clinical features and genotype phenotype correlation. , 2007, European journal of endocrinology.

[9]  M. Höfler,et al.  Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1. , 2007, Experimental and clinical endocrinology & diabetes.

[10]  K. Mulder,et al.  Menin links estrogen receptor activation to histone H3K4 trimethylation. , 2006, Cancer research.

[11]  M. Imamura,et al.  Multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas in Japan. , 2005, Oncology reports.

[12]  M. Brandi,et al.  Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. , 2005, The Journal of clinical endocrinology and metabolism.

[13]  B. Schaller.  Gender-related differences in prolactinomas. A clinicopathological study. , 2005, Neuro endocrinology letters.

[14]  T. Kameya,et al.  Recent advances in MEN1 gene study for pituitary tumor pathogenesis. , 2004, Frontiers of hormone research.

[15]  G. Thiéfin,et al.  Prevalence, characteristics and prognosis of MEN 1-associated glucagonomas, VIPomas, and somatostatinomas: study from the GTE (Groupe des Tumeurs Endocrines) registry. , 2004, Gastroenterologie clinique et biologique.

[16]  L. Hunyady,et al.  Genetic screening methods for the detection of mutations responsible for multiple endocrine neoplasia type 1. , 2004, Molecular genetics and metabolism.

[17]  R. Jensen,et al.  Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison Syndrome: A Prospective Study of 107 Cases and Comparison With 1009 Cases From the Literature , 2004, Medicine.

[18]  A. Vortmeyer,et al.  Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. , 2003, The Journal of clinical endocrinology and metabolism.

[19]  A. Gozzini,et al.  Multiple endocrine neoplasia type 1 , 2006, Reviews in endocrine & metabolic disorders.

[20]  A. Vortmeyer,et al.  Identical clonality of sporadic gastrinomas at multiple sites. , 2000, Cancer research.

[21]  A. Beckers,et al.  Somatic MEN1 gene mutation does not contribute significantly to sporadic pituitary tumorigenesis. , 1999, European journal of endocrinology.

[22]  P. Ruszniewski,et al.  Prognostic Factors in Patients With Zollinger-Ellison Syndrome and Multiple Endocrine Neoplasia Type 1 , 1999 .

[23]  P. Chanson,et al.  Germ-line mutation analysis in patients with multiple endocrine neoplasia type 1 and related disorders. , 1998, American journal of human genetics.

[24]  C. Larsson,et al.  Thymic carcinoids in multiple endocrine neoplasia type 1. , 1998, Journal of internal medicine.

[25]  Mignon,et al.  Diagnostic and therapeutic criteria in patients with Zollinger–Ellison syndrome and multiple endocrine neoplasia type 1 , 1998, Journal of internal medicine.

[26]  Y Wang,et al.  Positional cloning of the gene for multiple endocrine neoplasia-type 1. , 1997, Science.

[27]  C. Edwards,et al.  Clinical studies of multiple endocrine neoplasia type 1 (MEN1) , 1996, QJM : monthly journal of the Association of Physicians.

[28]  G. Faglia.  Epidemiology and pathogenesis of pituitary adenomas. , 1993, Acta endocrinologica.

[29]  J. Shepherd.  The natural history of multiple endocrine neoplasia type 1. Highly uncommon or highly unrecognized? , 1991, Archives of surgery.

[30]  J. Norton,et al.  Effect of parathyroidectomy in patients with hyperparathyroidism, Zollinger-Ellison syndrome, and multiple endocrine neoplasia type I: a prospective study. , 1987, Surgery.

[31]  J. V. van Heerden,et al.  Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type I. , 1986, Surgery.